The International Aids Conference is currently underway in Vienna right now and some exciting news has been announced there. A new vaginal gel containing an AIDs drug is excellent at curtailing HIV infections.
The gel was found to be both safe and acceptable when used once in the 12 hours before sex and once in the 12 hours after sex by women aged 18 to 40 years.
Salim Abdool Karim, one of the two leading co-researchers, told reporters in Vienna that the 889 women involved in the trial, conducted in the coastal city of Durban and a remote rural village, had largely used the gel as directed.
They were also given condoms and advice about sexually transmitted diseases, and tested for HIV once a month.
After 30 months, 98 women became infected with HIV – 38 in the group that got tenofovir in the gel and 60 in the group that got placebos.